Han et al. reported that MALAT1 acts as a tumor suppressor in glioma cells by downregulation of matrix metalloproteinase-2 (MMP2) and inactivation of the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) pathway [27]. Here, MMP2 is linked to glioma.